The DOI matches its Crossref record.
Organ Preservation Therapy Using Induction Plus Concurrent Chemoradiation for Advanced Resectable Oropharyngeal Carcinoma: A University of Pennsylvania Phase II Trial
Abstract
PURPOSE: To determine the efficacy, feasibility, and toxicity of a new regimen for locally advanced oropharyngeal carcinoma. PATIENTS AND METHODS: Patients had technically resectable stage III/IV squamous cell carcinoma of the oropharynx, exclusive of T1-2N1. Induction chemotherapy consisted of carboplatin (area under the curve formula equal to 6) and paclitaxel 200 mg/m 2 for two cycles, followed by re-evaluation. Patients with major response continued to definitive radiotherapy (70 Gy over 7 weeks) plus concurrent once-weekly paclitaxel (30 mg/m 2/wk). Patients with advanced neck disease also underwent post–radiation therapy neck dissection and two more chemotherapy cycles. RESULTS: Fifty-three patients were enrolled. Median follow-up was 31 months (minimum follow-up for survivors was 18 months). The major response rate to induction chemotherapy was 89%; 90% of patients had a complete response after concurrent chemoradiation. Actuarial survival at 3 years was 70%, and 3-year event-free survival was 59%. The 3-year actuarial locoregional control was 82% and the 3-year actuarial rate of distant metastases was 19%. Organ preservation was achieved in 77% of all patients. One patient (2%) died during therapy. Late grade 3 toxicity occurred in 24% of patients, consisting mainly of chronic dysphagia/aspiration and/or radiation soft tissue ulceration. The treatment-related mortality rate was 4% (two patients died from respiratory failure). CONCLUSION: Response to induction chemotherapy as studied in this trial was not useful as a predictive marker for ultimate outcome or organ conservation. Overall, however, this regimen offers good disease control and survival for patients with locally advanced oropharyngeal carcinoma, comparable with other concurrent chemoradiation programs. Further study of similar protocols is indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Transoral Robotic Surgery (TORS) for Base of Tongue Neoplasms
O'Malley, B. W., Weinstein, G. S., Snyder, W., & Hockstein, N. G. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000227184.90514.1a · Cited by 740
Self-citationFeng, F. Y., Kim, H. M., Lyden, T. H., Haxer, M. J., Worden, F. P., Feng, M., Moyer, J. S., Prince, M. E., Carey, T. E., Wolf, G. T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6199 · Cited by 349
Paccagnella, A., Morello, M., Da Mosto, M. C., Baruffi, C., Marcon, M. L., Gava, A., Baggio, V., Lamon, S., Babare, R., Rosti, G., et al. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0717-0 · Cited by 268
Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253
Metadata
- Authors
- Machtay, M., Rosenthal, D. I., Hershock, D., Jones, H., Williamson, S., Greenberg, M. J., Weinstein, G. S., Aviles, V. M., Chalian, A. A., & Weber, R. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-10-01
- Volume
- 20
- Issue
- 19
- Pages
- 3964-3971
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2054351351
- Cited by
- 223
- References
- 0
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Organ Preservation Therapy Using Induction Plus Concurrent Chemoradiation for Advanced Resectable Oropharyngeal Carcinoma: A University of Pennsylvania Phase II Trial. https://app.cochat.ai/papers/10.1200/jco.2002.11.026
- The paper
- Machtay, M., Rosenthal, D. I., Hershock, D., Jones, H., Williamson, S., Greenberg, M. J., Weinstein, G. S., Aviles, V. M., Chalian, A. A., & Weber, R. S. (2002). Organ Preservation Therapy Using Induction Plus Concurrent Chemoradiation for Advanced Resectable Oropharyngeal Carcinoma: A University of Pennsylvania Phase II Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2002.11.026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.